Suchergebnisse - "Curigliano, G"

PubPharm (152)

91

Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer : TREnd trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2018

von Malorni, L. | Curigliano, G. | Minisini, A. | +19

92

4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2018

von Cardoso, F. | Senkus, E. | Costa, A. | +39

93

The use of breast imaging for predicting response to neoadjuvant lapatinib, trastuzumab and their combination in HER2-positive breast cancer : Results from Neo-ALTTO

enthalten in: European journal of cancer (Oxford, England : 1990) | 2018

von Di Cosimo, S. | Campbell, C. | Azim, H. | +18

94

Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date

in: Breast Cancer: Targets and Therapy | 2018

von Criscitiello C | Viale G | Curigliano G | +1

95

Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date [Corrigendum]

in: Breast Cancer: Targets and Therapy | 2018

von Criscitiello C | Viale G | Curigliano G | +1

96

Reply to 'The St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017 : the point of view of an International Panel of Experts in Radiation Oncology' by Kirova et al

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2018

von Dubsky, P. | Curigliano, G. | Burstein, H. | +52

CommentOn: Ann Oncol. 2017 Aug 1;28(8):1700-1712. - PMID 28838210

97

A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2018

von Criscitiello, C. | Bayar, M. | Curigliano, G. | +12

98

3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2017

von Cardoso, F. | Costa, A. | Senkus, E. | +42

ErratumFor: Ann Oncol. 2017 Jan 1;28(1):16-33. - PMID 28177437

99

De-escalating and escalating treatments for early-stage breast cancer : the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2017

von Curigliano, G. | Burstein, H. | Winer, E. | +52

CommentIn: Ann Oncol. 2018 Jan 1;29(1):280-281. - PMID 29045510

100

Safety and immunogenicity of neoadjuvant treatment using WT1-immunotherapeutic in combination with standard therapy in patients with WT1-positive Stage II/III breast cancer : a randomized Phase I study

enthalten in: Breast cancer research and treatment | 2017

von Higgins, M. | Curigliano, G. | Dieras, V. | +14